Shuang-shuang Dong
Key Laboratory Of Carcinogenesis And Cancer Invasion
Zhongshan, 200032, China
Zhongshan, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
ALOXE3 transcriptionally regulated by activating transcription factor 3 promotes HCC ferroptosis via ERK and JNK signaling pathway.
Journal: International immunopharmacology
Published: April 26, 2025
Genomic and transcriptomic profiling reveals key molecules in metastatic potentials and organ-tropisms of hepatocellular carcinoma.
Journal: Cellular signalling
Published: November 19, 2022
Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma.
Journal: Cellular and molecular gastroenterology and hepatology
Published: September 25, 2021
Exosomal miR-3682-3p Suppresses Angiogenesis by Targeting ANGPT1 via the RAS-MEK1/2-ERK1/2 Pathway in Hepatocellular Carcinoma.
Journal: Frontiers in cell and developmental biology
Published: November 25, 2020
Correction to: Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 01, 2019
Genetic Alterations and Transcriptional Expression of m6A RNA Methylation Regulators Drive a Malignant Phenotype and Have Clinical Prognostic Impact in Hepatocellular Carcinoma.
Journal: Frontiers in oncology
Published: July 27, 2019
Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 06, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026